The current financial score of iSpecimen Inc is 6.80. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 151.94K, representing a year-over-year decrease of 78.69%, while its net profit experienced a year-over-year decrease of 30.13%.
The current valuation score of iSpecimen Inc is 8.80. Its current P/E ratio is -0.00, which is 0.00% below the recent high of -0.00 and -52563.16% above the recent low of -2.00.
No earnings forecast score is currently available for iSpecimen Inc. The Software & IT Services industry's average is 7.58.
The current price momentum score of iSpecimen Inc is 5.23. Currently, the stock price is trading between the resistance level at 1.71 and the support level at 1.02, making it suitable for range-bound swing trading.
The current institutional shareholding score of iSpecimen Inc is 3.00. The latest institutional shareholding proportion is 0.39%, representing a quarter-over-quarter decrease of 89.20%.
The current risk assessment score of iSpecimen Inc is 2.01. The company's beta value is 1.66. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.